Showing results (301-310 of 316) with videos related to
Sort By:
Pageof 32
Circulation|April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical TrialDuk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.The New England Journal of Medicine|March 17, 2015
Trial of everolimus-eluting stents or bypass surgery for coronary diseaseSeung-Jung Park, Jung-Min Ahn, Young-Hak Kim, et al.Journal of the American College of Cardiology|October 2, 2010
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trialDuk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, et al.The American Journal of Cardiology|September 26, 2013
Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIABETES II trialGyung-Min Park, Seung-Whan Lee, Seong-Wook Park, et al.European Heart Journal|August 31, 2025
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trialDo-Yoon Kang, Seong-Bong Wee, Jung-Min Ahn, et al.JACC. Cardiovascular Interventions|October 25, 2011
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) TrialDuk-Woo Park, Young-Hak Kim, Hae-Geun Song, et al.Journal of the American College of Cardiology|March 12, 2011
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trialSeung-Whan Lee, Seong-Wook Park, Young-Hak Kim, et al.American Journal of Hematology|August 1, 2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemiaSung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, et al.Pacing and Clinical Electrophysiology : PACE|December 22, 2016
Variants of Brugada Syndrome and Early Repolarization Syndrome: An Expanded Concept of J-Wave SyndromeSung-Hwan Kim, Gi-Byoung Nam, Sung-Cheol Yun, et al.Leukemia|March 18, 2023
The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trialKyoo-Hyung Lee, Suk Ran Yoon, Jeong-Ryeol Gong, et al.Pageof 32